How to talk about vaccines: does different communication help people decide to get vaccinated?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses an online randomized controlled design to test three approaches for informing people about vaccination: a control condition, an information website, and a slideshow/carousel format. Participants are adults from Germany or Colombia who are asked about their vaccination status and risk perceptions, then randomly assigned to one of the three arms. The aim is to see if tailored communication can increase informed vaccination decisions regarding TBE or yellow fever vaccines. The project builds on prior qualitative and quantitative work conducted in Europe and South America and involves collaboration with a Dutch research institute and a Colombian research center.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* German citizens
* Colombian citizens

Exclusion Criteria:

* Citizens of all other countries

Where it's running

• Charité - Universitätsmedizin Berlin, Berlin-Mitte
  Berlin, State of Berlin, Germany Recruiting

Study contacts

• Study coordinator: Odette Wegwarth, Prof. Dr.
• Email: odette.wegwarth@charite.de
• Phone: +49 30 450 531 074

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-generated treatment recommendations for precision oncology

  A non-interventional study tests whether AI-generated treatment options for advanced solid tumors align with what doctors would personally recommend.

  Recruiting Charite University, Berlin, Germany · Berlin · NCT07897110

• DHEA add-on to standard antidepressants for treatment-resistant depression

  This trial tests whether adding 100 mg/day of DHEA to patients’ current antidepressant treatment helps people with treatment-resistant depression feel better.

  Recruiting at 9 sites Phase 3 Charite University, Berlin, Germany · Berlin, State of Berlin and 8 other locations · NCT07843927

• Context-adapted quality indicators for early sepsis care in Sub-Saharan Africa

  A group of sepsis experts in Sub-Saharan Africa will participate in a series of online surveys and feedback meetings to agree on practical quality indicators for early sepsis care.

  Recruiting Charite University, Berlin, Germany · Kumasi · NCT07711535

• TNPO2-related disorders registry

  This international registry tests how TNPO2 gene variants relate to neurodevelopmental issues by collecting medical, genetic, and developmental data from people with pathogenic TNPO2 variants.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07699510

• International TRPM3 Disorder Registry

  This registry tests how TRPM3-associated disorders progress by collecting and comparing patient data over time to learn about treatments and quality of life.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07690111

• High-fiber diet with short-term fasting during melanoma immunotherapy

  This study tests whether a high-fiber diet, with or without short-term fasting, can help people with melanoma better tolerate and respond to immune checkpoint inhibitors.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07680452

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.